Enforcement record

協力・後援 disclosure naming 都道府県

都道府県 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure9 October 2019

Action type

協力・後援

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

9 October 2019

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority: Ministry of Health, Labour and Welfare
Official source URL: Recorded by RegBase
Entity match: Not confirmed; shown under the published name
Kiroku preservation: Completed archive verified; Captured: May 4, 2026, 03:01 PM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Open the official source links in the section below to review the original disclosure.

Action summary

Company: 都道府県Japanese only
Original: 都道府県
Governing law: Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type: 協力・後援
協力・後援
Action date: 9 October 2019
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 地方行政

Violation

Machine-translated summary — verify against original

On October 9, 2019, the prefectural government provided cooperation and support to the Ministry of Health, Labour and Welfare for the implementation of 'Medicine and Health Week.' The activities included initiatives and events aimed at promoting the proper use of pharmaceuticals and raising awareness of the roles of pharmacists and other healthcare professionals.

Show original Japanese text

医薬品の適正使用や薬剤師などの専門家の役割の普及啓発に関する取組・イベントの開催

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-05-04T06:01:04.441+00:00
Evidence checked: 2026-05-04T06:01:04.441+00:00
Archive captured: 2026-05-04T06:01:21.049109+00:00

Show audit JSON

{
  "record": {
    "id": "2430ceeb-909e-477d-81e4-0f7cd80cb036",
    "url": "https://regbase.jp/en/enforcement/yakkiho-du-dao-fu-xian-20191009",
    "company_name_original": "都道府県",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "薬機法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "協力・後援",
      "en": "協力・後援"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 60,
    "method": "extracted_japanese_name",
    "method_label": "Company name extracted from the Japanese public disclosure",
    "notes": "The linked company profile has not been verified under the current identity policy."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/yakkiho-du-dao-fu-xian-20191009",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_07205.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/7faec8f436qsjuek",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_07205.html",
    "archiveCapturedAt": "2026-05-04T06:01:21.049109+00:00",
    "extractedAt": "2026-05-04T06:01:04.441+00:00",
    "translatedAt": "2026-07-06T07:52:08.988+00:00",
    "evidenceCheckedAt": "2026-05-04T06:01:04.441+00:00",
    "generatedAt": "2026-09-18T20:15:15.297Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.